Memantine for the Treatment of Dementia: A Review on its Current and Future Applications

Cited by (247)

Items 101–200 of 247

1. Functional MRI technologies in the study of medication treatment effect on Alzheimer's disease
   Hui Guo, Lukas A. Grajauskas, Baraa Habash, Ryan C.N. D’Arcy, Xiaowei Song · 2018 · Aging Medicine
2. Rethinking Pharmacological Nomenclature
   Roland Seifert · 2018 · Trends in Pharmacological Sciences
3. Cornel Iridoid Glycoside Suppresses Hyperactivity Phenotype in rTg4510 Mice through Reducing Tau Pathology and Improving Synaptic Dysfunction
   Denglei Ma, Yi Luo, Rui Huang, Zirun Zhao, Li Zhang, Yali Li, Qi Wang, Lin Li, Lan Zhang · 2020 · Current Medical Science
4. Promoting Endogenous Neurogenesis as a Treatment for Alzheimer’s Disease
   Qiang Zhang, Jingyue Liu, Li Chen, Ming Zhang · 2022 · Molecular Neurobiology
5. An inclusive study of recent advancements in Alzheimer's disease: A comprehensive review
   Sukanya Singh, Mitali Mahajan, Dhawal Kumar, Kunika Singh, Mehvish Chowdhary, Amit · 2023 · Neuropeptides
6. Advances in the Study of the Pathology and Treatment of Alzheimer’s Disease and Its Association with Periodontitis
   Dan Tang, Chang Sun, Jumei Yang, Lili Fan, Yonggang Wang · 2023 · Life
7. Morphing cholinesterase inhibitor amiridine into multipotent drugs for the treatment of Alzheimer's disease
   Eva Mezeiová, Lukáš Prchal, Martina Hrabinová, Ľubica Múčková, Lenka Pulkrabkova, Ondřej Soukup, Anna Misiachna, Jiří Janoušek, Jakub Fibigar, Tomas Kucera et al. · 2024 · Biomedicine & Pharmacotherapy
8. Morphological profiling in human neural progenitor cells classifies hits in a pilot drug screen for Alzheimer’s disease
   Amina McDiarmid, K. Gospodinova, Richard J. R. Elliott, John C. Dawson, Rebecca E. Graham, Marie-Thérèse A. El-Daher, Susan M. Anderson, Sophie C. Glen, S. Glerup, N. Carragher et al. · 2024 · Brain Communications
9. In vivo Evaluation of a Newly Synthesized Acetylcholinesterase Inhibitor in a Transgenic Drosophila Model of Alzheimer’s Disease
   Giuseppe Uras, Alessia Manca, Pengfei Zhang, Zsuzsa Markus, Natalie Ann Mack, Stephanie Allen, Marco Bo, Shengtao Xu, Jinyi Xu, Μάριος Γεωργίου et al. · 2021 · Frontiers in Neuroscience
10. I2-Imidazoline Ligand CR4056 Improves Memory, Increases ApoE Expression and Reduces BBB Leakage in 5xFAD Mice
    Bibiana Castagna Mota, Nathan Ashburner, Laura Esther Abelleira, Liyueyue Liu, Robertas Aleksynas, Lucio Claudio Rovati, Gianfranco Caselli, Magdalena Sastre · 2022 · International Journal of Molecular Sciences
11. PACAP: A promising disease-modifying target for Alzheimer's disease
    Rehana Basri, Hayder Mutter Al-Kuraishy, Mohamed N Fawzy, Mubarak Alruwaili, Gaber El‐Saber Batiha · 2025 · Life Sciences
12. Early Chronic Memantine Treatment-Induced Transcriptomic Changes in Wild-Type and Shank2-Mutant Mice
    Ye-Eun Yoo, Seungjoon Lee, Woohyun Kim, Hyosang Kim, Changuk Chung, Seungmin Ha, Jinsu Park, Yeonseung Chung, Hyojin Kang, Eunjoon Kim · 2021 · Frontiers in Molecular Neuroscience
13. Treatment of noncognitive neuropsychiatric disorders in Alzheimer's disease
    Локшина Анастасия Борисовна, Д. А. Гришина · 2021 · Neurology neuropsychiatry Psychosomatics
14. Tonic Activation of Extrasynaptic NMDA Receptors Decreases Intrinsic Excitability and Promotes Bistability in a Model of Neuronal Activity
    David Gall, Geneviève Dupont · 2019 · International Journal of Molecular Sciences
15. Cornel Iridoid Glycoside Protects Against STAT1-Dependent Synapse and Memory Deficits by Increasing N-Methyl-D-aspartate Receptor Expression in a Tau Transgenic Mice
    Denglei Ma, Rui Huang, Kaiwen Guo, Zirun Zhao, Weipeng Wei, Li-Hong Gu, Lin Li, Lan Zhang · 2021 · Frontiers in Aging Neuroscience
16. Memantine protects the cultured rat hippocampal neurons treated by NMDA and amyloid β1–42
    Nataliia M. Rozumna, Vita V. Hanzha, Elena A. Lukyanetz · 2023 · Frontiers in Neuroscience
17. Polymer–drug conjugates as nano-sized multi-targeting systems for the treatment of Alzheimer's disease
    Nuruddin Mahadik, Gemma Ann Barron, Paul Kong Thoo Lin, Colin J. Thompson · 2024 · RSC Pharmaceutics
18. The CITIMERIVA Study: CITIcoline plus MEmantina plus RIVAstigmine in Older Patients Affected with Alzheimer’s Disease
    Alberto Castagna, Ciro Manzo, Andrea Fabbo, Roberto Lacava, Carmen Ruberto, Giovanni Ruotolo · 2021 · Clinical Drug Investigation
19. Memantine Use and Cognitive Decline in Huntington's Disease: An Enroll‐HD Study
    Amy C. Ogilvie, Jordan L. Schultz · 2023 · Movement Disorders Clinical Practice
20. The Computer Simulation of Therapy with the NMDA Antagonist in Excitotoxic Neurodegeneration in an Alzheimer’s Disease-like Pathology
    Dariusz Świetlik, Aida Kusiak, Marta Krasny, J Białowas · 2022 · Journal of Clinical Medicine
21. Virtual Therapy with the NMDA Antagonist Memantine in Hippocampal Models of Moderate to Severe Alzheimer’s Disease, in Silico Trials
    Dariusz Świetlik, J Białowas, Aida Kusiak, Marta Krasny · 2022 · Pharmaceuticals
22. Effect of pharmacological manipulations on Arc function
    Dina W. Yakout, Nitheyaa Shree Ramesh, Angela M. Mabb · 2020 · Current Research in Pharmacology and Drug Discovery
23. Mesenchymal Stem Cells Applications in Alzheimer's Disease
    Oluwatosin Debola Oyebode, Pınar Tulay · 2023 · Global Medical Genetics
24. Effects of NMDAR Antagonist on the Regulation of P-MARCKS Protein to Aβ1−42 Oligomers Induced Neurotoxicity
    Yudong Liu, Peng Zhang, Yabing Zheng, Chunlin Yang, Tong Du, Meng‐Ru Ge, Xiaotian Chang, Rui‐Sheng Duan, Guozhao Ma · 2018 · Neurochemical Research
25. The possibilities of diagnosing and treating cognitive impairment at non-dementia stages
    А. Yu. Emelin · 2020 · Neurology neuropsychiatry Psychosomatics
26. N-Methyl-D-Aspartate Receptors Mediate Synaptic Plasticity Impairment of Hippocampal Neurons Due to Arsenic Exposure
    Xiaona Liu, Jing Wang · 2022 · Neuroscience
27. Glutamate’s Effects on the N-Methyl-D-Aspartate (NMDA) Receptor Ion Channel in Alzheimer’s Disease Brain: Challenges for PET Radiotracer Development for Imaging the NMDA Ion Channel
    Nehal M. Shah, Nane Ghazaryan, Noresa L. Gonzaga, Cayz G. Paclibar, Agnes P. Biju, Christopher Liang, Jogeshwar Mukherjee · 2023 · Molecules
28. Roles of glutamate receptors in a novel in vitro model of early, comorbid cerebrovascular, and Alzheimer’s diseases
    Elisa Nicoloso Simões Pires, Sergio Teixeira Ferreira, Rafael Linden · 2020 · Journal of Neurochemistry
29. Effect of Memantine Treatment and Combination with Vitamin D Supplementation on Body Composition in the APP/PS1 Mouse Model of Alzheimer’s Disease Following Chronic Vitamin D Deficiency
    Dickson Y. Wong, Dana N Broberg, Jagroop Singh Doad, Joseph U. Umoh, Miranda Bellyou, Chris J. D. Norley, David Wayne Holdsworth, Manuel Montero‐Odasso, Olivier Beauchet, Cédric Annweiler et al. · 2021 · Journal of Alzheimer s Disease
30. Neuroprotective Agents with Therapeutic Potential for COVID-19
    César A. Zaa, Clara Espitia, Karen Lizbeth Reyes-Barrera, Zhiqiang An, Marco Antonio Velasco-Velázquez · 2023 · Biomolecules
31. Mutant prion protein enhances NMDA receptor activity, activates PKC, and triggers rapid excitotoxicity in mice
    Joie Lin, Julia A. Callender, Joshua E. Mayfield, Daniel B. McClatchy, Daniel Ojeda-Juárez, Mahsa Pourhamzeh, Katrin Soldau, Timothy D. Kurt, Garrett A Danque, Helen Khuu et al. · 2025 · Journal of Clinical Investigation
32. Amyloid‐Beta Pathology Increases Synaptic Engulfment by Glia in Feline Cognitive Dysfunction Syndrome: A Naturally Occurring Model of Alzheimer's Disease
    Robert I. McGeachan, Lucy Ewbank, Meg Watt, Lorena Sordo, Alexandra J. Malbon, Muhammad Khalid Farooq Salamat, Makis Tzioras, João Miguel De Frias, Jane Tulloch, Fiona E. Houston et al. · 2025 · European Journal of Neuroscience
33. HMTM-Mediated Enhancement of Brain Bioenergetics in a Mouse Tauopathy Model Is Blocked by Chronic Administration of Rivastigmine
    Renato X. Santos, Valeria Melis, Elizabeth A. Goatman, Michael Leith, Thomas C. Baddeley, John M. D. Storey, Gernot Riedel, Claude M. Wischik, Charles R. Harrington · 2022 · Biomedicines
34. Pharmacological and Non-Pharmacological Interventions to Improve Sleep in People with Cognitive Impairment: A Systematic Review and Meta-Analysis
    Patrick Crowley, Mark R. O’Donovan, Peter Leahy, Evelyn Flanagan, Rónán Ó’Caoimh · 2025 · International Journal of Environmental Research and Public Health
35. Neuroprotective Strategies in Glaucoma - Translation to Clinical Trials
    Clarissa Ern Hui Fang, Li Guo, Daniel Hill, Timothy E. Yap, Maria Francesca Cordeiro · 2020 · OBM Neurobiology
36. Effect of memantine on expression of Bace1-as and Bace1 genes in STZ-induced Alzheimeric rats
    Parisa Azadfar, Zahra Noormohammadi, Maryam Noroozıan, Akram Eidi, Pejman Mortazavi · 2020 · Molecular Biology Reports
37. Nanoporous Membranes for the Filtration of Proteins from Biological Fluids: Biocompatibility Tests on Cell Cultures and Suggested Applications for the Treatment of Alzheimer’s Disease
    Thomas Gabriel Schreiner, Bogdan-Ionel Tamba, Cosmin Teodor Mihai, Adam Lörinczi, Mihaela A. Baibarac, Romeo Cristian Ciobanu, Bogdan Ovidiu Popescu · 2022 · Journal of Clinical Medicine
38. Alzheimer’s: Epidemiology, Pathophysiology, Diagnosis, and Treatments
    A.T. Faslu Rahman, Arpita Jaiswal, Pankaj Keshari, Dhiraj Kumar Singh · 2025 · Springer eBooks
39. A Comprehensive Review of Herbal Medicines for the Treatment of Alzheimer's Disease
    Sumbul Shadab, GSN Koteswara Rao, Deepika Paliwal, Devdhar Yadav, Aftab Alam, Amit Singh, Md. Jaha Sultana · 2023 · Current Traditional Medicine
40. Memantine/Rosuvastatin Therapy Abrogates Cognitive and Hippocampal Injury in an Experimental Model of Alzheimer's Disease in Rats: Role of TGF-β1/Smad Signaling Pathway and Amyloid-β Clearance
    Esraa F. Zidan, Nesrine S. El-Mezayen, Safaa H. El‐Rewini, Elham A. Afify, Mennatallah A. Ali · 2024 · Journal of Neuroimmune Pharmacology
41. Memantine has a nicotinic neuroprotective pathway in acute hippocampal slices after an NMDA insult
    Yancy Ferrer‐Acosta, Sergio R. Rodríguez-Massó, Dinely Pérez, Vesna A. Eterović, Pedro A. Ferchmin, Antonio Henrique B. Martins · 2022 · Toxicology in Vitro
42. Translation from Preclinical Research to Clinical Trials: Transdermal Drug Delivery for Neurodegenerative and Mental Disorders
    Phuong‐Trang Nguyen‐Thi, Tuong Kha Vo, Huong Thuy Le, Nhat Thang Thi Nguyen, Thuy Trang Nguyen, Vo Van Giau · 2024 · Pharmaceutical Research
43. Mapping hippocampal glutamate in healthy aging with in vivo glutamate-weighted CEST (GluCEST) imaging
    Maggie K. Pecsok, Heather Robinson, Ally Atkins, Monica E. Calkins, Mark A. Elliott, Arianna E. Mordy, Jacquelyn Stifelman, Ruben C. Gur, Paul J. Moberg, Ravi Prakash Reddy Nanga et al. · 2025 · Frontiers in Aging Neuroscience
44. Time-Dependent Long-Term Effect of Memantine following Repetitive Mild Traumatic Brain Injury
    Masen L. Boucher, Grace M. Conley, Nicholas J. Morriss, Sara Ospina-Mora, Jianhua Qiu, Rebekah Mannix, William Paul Meehan III · 2024 · Journal of Neurotrauma
45. Tryptophan in banana peel (Musa paradisiaca) as an anti-dementia alternative treatment: A narrative review
    Daffara Kinanthi Lustikaiswi, Sapto Yuliani, Rahmah Annura, Elmi Rahmadani · 2021 · Jurnal kedokteran dan kesehatan Indonesia
46. Cognitive- and memory-enhancing effects of Augmentin in Alzheimer’s rats through regulation of gene expression and neuronal cell apoptosis
    Mahmoud K Kandeel, Mohamed Aly Morsy, Hany M. Abd El‐Lateef, Mohamed Marzok, Hossam Saad EL-BELTAGI, Khalid M. Alkhodair, Ibrahim F. Albokhadaim, Katharigatta Narayanaswamy Venugopala · 2023 · Frontiers in Pharmacology
47. Predicting Progression to Clinical Alzheimer’s Disease Dementia Using the Random Survival Forest
    Shangchen Song, Alzheimer’s Disease Neuroimaging Initiative, Breton Michael Asken, Melissa J. Armstrong, Yang Yang, Zhigang Li · 2023 · Journal of Alzheimer s Disease
48. Effect of Memantine on QT/QTc Interval in a Healthy Korean Population
    Jin‐Woo Park, Kyoung‐Ah Kim, Ji Young Park · 2021 · Clinical Pharmacology in Drug Development
49. miRNAs and Stem Cells as Promising Diagnostic and Therapeutic Targets for Alzheimer’s Disease
    Emad M. Elzayat, Sherif A. Shahien, Ahmed Abdou El-Sherif, Mohamed Hosney · 2023 · Journal of Alzheimer s Disease
50. Potentiation of NMDA-Mediated Responses by Amyloid-β Peptide 1-40 in Rat Sympathetic Preganglionic Neurons
    Chih‐Chia Lai, Hsuan Lo, Hong-Guo Lin, Hsun-Hsun Lin · 2019 · Journal of Alzheimer s Disease
51. Alzheimer’s disease and memantine effects on NMDA-receptor blockade: non-invasive in vivo insights from magnetoencephalography
    Juliette H. Lanskey, Amirhossein Jafarian, Laura E. Hughes, Melek Karadag, Ece Kocagöncü, Matthew A Rouse, Natalie Adams, Michelle Naessens, Vanessa Raymont, Mark W. Woolrich et al. · 2025 · Molecular Psychiatry
52. The investigation of glutamate transporter 1 (GLT-1) degradation pathway in glioblastoma cells
    Düriye Nur Dağdelen, Ayşenur Akkulak, Gizem Dönmez · 2021 · Molecular Biology Reports
53. Extravaganza of Nanobiotechnology in the Diagnosis and Treatment of Dementia Patients
    Sankha Bhattacharya · 2022 · Current Pharmaceutical Biotechnology
54. Can supplementation with antioxidants improve cognitive functions in patients with multiple sclerosis? A literature review
    Ali Akbar Rezaei, Majid Hamidi, Homa Seyedmirzaei, Abdorreza Naser Moghadasi · 2025 · Annals of Medicine and Surgery
55. Biased agonism in psychopharmacology: an opportunity to improve efficacy and safety of treatments
    Gia Han Le, Sabrina Wong, Stavroula I. Bargiota, Jennifer Swainson, Heidi Ka Ying Lo, Diana K. Orsini, Kayla M. Teopiz, Hernan Felipe Guillen-Burgos, Poh Khuen Lim, Roger S. McIntyre · 2025 · CNS Spectrums
56. Protective role of fucoidan against cognitive deficits and redox imbalance in a scopolamine-induced Alzheimer’s disease model in rats
    Maryam Salmani, Mahdieh Anoush, Ali Kalantari‐Hesari, Armin Jahani Maleki, Fatemeh Nouri, Mir‐Jamal Hosseini, Mojdeh Mohammadi · 2025 · Scientific Reports
57. Mild Cognitive Impairment: Some Aspects of Diagnosis and Therapy
    Д. А. Гришина, Moscow, Russian Federation, A.B. Lokshina · 2021 · Doctor Ru
58. Development of memantine as a drug for Alzheimer’s disease: A review of preclinical and clinical studies
    Yusuf S. Althobaiti · 2020 · Tropical Journal of Pharmaceutical Research
59. Leveraging artificial intelligence for drug development and drug discovery
    Shilpa Chatterjee, Sayantan Kundu, Nandan Sarkar · 2025 · Elsevier eBooks
60. Research progress on 40 Hz sensory stimulation for the treatment of Alzheimer’s disease
    Bing Tang, Ming Tao · 2026 · Frontiers in Aging Neuroscience
61. Excitotoxicity, oxidative stress, and neuronal injury
    Snjezana Zaja‐Milatovic, Ramesh C. Gupta · 2020 · Elsevier eBooks
62. Cognitive Enhancers
    Rabin Dahal, Rajesh R. Tampi · 2021 · Springer eBooks
63. Reevaluating Alzheimer’s disease treatment: Can phytochemicals bridge the therapeutic Gap?
    Kishor Kumar Roy, Dinesh Kumar Mehta, Rina Das · 2025 · Neuroscience
64. Sex differences in risk factors associated with Alzheimer’s dementia patients with irritability and anger
    Philip Cole Brewer, Timi Kehinde Ojo, Killian Joseph Bucci, Claire O’Brien, Dami Taiwo Ojo, Emmanuel I. Nathaniel, Nathan Gerhard Faulstich, Adebobola Imeh‐Nathaniel, Richard L. Goodwin, Thomas I. Nathaniel · 2025 · Archives of Gerontology and Geriatrics Plus
65. Structure-Based Virtual Screening to Identify Negative Allosteric Modulators of NMDA
    Zaid Anis Sherwani, Ruqaiya Khalil, Mohammad Nur‐e‐Alam, Sarfaraz Ahmed, Zaheer Ul‐Haq · 2022 · Medicinal Chemistry
66. The evolution of ideas about the treatment of Alzheimer’s disease: from the past to the present day
    S. V. Vorobev, А. Yu. Emelin, S. N. Yanishevskij · 2022 · Russian neurological Journal
67. Alzheimer's Disease and the Aging Brain: A Review of Current Etiology and Treatments
    Alexandra Hulbert, Julia Bazinet, Justine McClellan · 2022 · Journal of Student Research
68. Synthesis and Biological Evaluation of a Library of Sulfonamide Analogs of Memantine to Target Glioblastoma
    John E. Philo, Jenna D. Caudle, Reema N. Moussa, Patrick M. Kampmeyer, Tasfia R. Hasin, David K. Seo, Robert J. Sheaff, Angus A. Lamar · 2023 · ChemMedChem
69. Combination strategy employing BACE1 inhibitor and memantine to boost cognitive benefits in Alzheimer’s disease therapy
    Abu Md Mamun Tarif, Hasi Huhe, Masuo Ohno · 2024 · Psychopharmacology
70. Herbal medicinal plants for the treatment of memory impairment: A futuristic approach for neurological Studies
    Awaneet Kaur, Aftab Alam, Tarique Mahmood, Farogh Ahsan · 2023 · Annals of Phytomedicine An International Journal
71. Comparative analysis of the effectiveness of donepezil monotherapy and combination therapy with donepezil and akatinol memantine in patients with Alzheimer's disease at the stage of mild dementia
    О. Н. Ткачева, Н. К. Рунихина, Elen A. Mkhitaryan, N. N. Koberskaya, Т. М. Маневич · 2020 · Russian neurological Journal
72. Memantine and Alzheimer's disease
    Sergio del Río‐Sancho · 2020 · Elsevier eBooks
73. Targeting mitochondrial ATP production of glioblastoma using sulfonamide and amide analogs of amantadine and memantine as metabolic inhibitors
    John E. Philo, Zachary C. Brandeburg, Tasfia R. Hasin, Ian J. Costello, Robert J. Sheaff, Angus A. Lamar · 2025 · Results in Chemistry
74. Recent advances towards BACE1 drug discovery and therapeutics design
    Saim Imran, Meera Patel, Meissam Noroozifar, Kağan Kerman · 2026 · RSC Medicinal Chemistry
75. State-specific inhibition of NMDA receptors by memantine provides insight into NMDAR channel blocker tolerability
    Matthew B. Phillips, Nadya V. Povysheva, Elizabeth G. Neureiter, Aparna Nigam, Karen A. Hartnett, Johannes W. Hell, Elias Aizenman, Jon W. Johnson · 2026 · Science Advances
76. Lamotrigine enhances the neuroprotective effects of memantine on aluminum chloride-induced behavioral changes in rats
    Raafat A. Abdel‐Aal, Hanan S.M. Farghaly, AndrewZ Zakaria · 2018 · Journal of Current Medical Research and Practice
77. Administration of Aripiprazole Alleviates Memory Impairment and Restores Damaged Glutamatergic System in 5xFAD Mice
    Hae‐June Lee, Hyun‐Yong Kim, Se Jong Oh, Yeonghoon Son, Kyung Jun Kang, Kyung Rok Nam, Jae Yong Choi · 2024 · Molecular Imaging and Biology
78. Therapeutic Modalities Targeting Tau Protein in Alzheimer’s Disease
    Thomas Gabriel Schreiner, Liviu Iacob, Carmen Vasilache, Oliver Daniel Schreiner · 2025 · Journal of dementia and Alzheimer's disease
79. Down syndrome: a model for chromosome abnormalities
    Cassia Overk, William Cary Mobley · 2022 · Elsevier eBooks
80. Morphological profiling by Cell Painting in human neural progenitor cells classifies hit compounds in a pilot drug screen for Alzheimer’s disease
    Amina McDiarmid, Katerina Gospodinova, Richard J. R. Elliott, John C. Dawson, Rebecca E. Hughes, Susan Maguire Anderson, Sophie Glen, Simon Glerup, Neil O. Carragher, Kathryn Louise Evans · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
81. State-specific inhibition of NMDA receptors by memantine depends on intracellular calcium and provides insights into NMDAR channel blocker tolerability
    Matthew B. Phillips, Nadya V. Povysheva, Karen A. Hartnett, Elias Aizenman, Jon W. Johnson · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
82. Tau Protein: Targets And Development Against Alzheimer’s Disease
    Sonal Dubey, Mahesh AR · 2023 · BENTHAM SCIENCE PUBLISHERS eBooks
83. Hurdles and Strategies in Treating Alzheimer’s Disease
    Tazeen Qureshi, Smita Eknath Desale, Hariharakrishnan Chidambaram, Subashchandrabose Chinnathambi · 2024 · Springer eBooks
84. Prescription cascades associated with acetylcholinesterase inhibitors use: a high-throughput sequence symmetry analysis
    Danielle Newby, Sai Sumedha Bobba, Berta Raventós, Elin J Rowlands, Xihang Chen, Laura Molina‐Porcel, Carlen Reyes, Talita Duarte‐Salles, Antonella Delmestri, Wai Yi Man et al. · 2026 · Age and Ageing
85. Computational Modeling of NMDAR-Mediated Calcium Dysregulation in Hippocampal Dendritic Spines in Alzheimer's Disease
    Shyam Pranav G, Amritanshu Gupta · 2025 · Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC)
86. Treatment options for Alzheimer’s Disease: An overview of the amyloid, tau, and alternate hypotheses
    Kaan Eroltu · 2023 · Journal of High School Science
87. MeMAGEN: A Phase IIa/IIb open‐label trial of memantine testing safety and tolerability in sickle cell patients
    Ariel Koren, Carina Levin, Leonid Livshits, Fabio Valeri, Sari Peretz, Sivan Raz, Anna Y. Bogdanova, Max Gassmann · 2026 · HemaSphere
88. Exploring cannabinoid modulation on autophagy mechanisms in Alzheimer’s disease: a review
    Claudia Ntsapi, Morné Weyers, Rosa M. Chinheya, T. Jim, Motlalepula Gilbert Matsabisa · 2026 · Frontiers in Pharmacology
89. Mechanisms to medicines: navigating drug repurposing strategies in Alzheimer’s disease
    Sara Akhtar Khan, Khushi Raza, Prachi Tiwari, Mohamed El‐Tanani, Syed Arman Rabbani, Suhel Parvez · 2026 · Frontiers in Aging Neuroscience
90. In vivo imaging of glutamate uncovers the neuroprotective effects of nicotinamide riboside on excitotoxicity in an Alzheimer’s mouse model
    Anshuman Swain, Narayan Datt Soni, Ryan B. Gaspar, James G. Davis, Fang Liu, Halvor M. Juul, Ravi Prakash Reddy Nanga, Joseph A. Baur, Ravinder Reddy · 2026 · Alzheimer s Research & Therapy
91. Comparative evaluation of machine learning algorithms for Alzheimer’s disease detection
    Shamneesh Sharma, Tanima Thakur, Chetan Banbarilal Sharma, Komal Sharma, Hsin-Yuan Chen · 2026 · Discover Computing
92. AETA peptide contributes to Alzheimer’s disease signature of synapse dysfunction
    Jade Dunot, Carine Gandin, Marin Truchi, Giulia Pirro, Sébastien Moréno, Agathe Launay, Benjamin Azoulay, Hugo Landra, Sandy Ma Yishan, Luc Buée et al. · 2026 · Acta Neuropathologica
93. Allosteric modulation of ionotropic and G protein-coupled receptors in Alzheimer's disease: A neuroprotective strategy and therapeutic implications
    Ali Fereidouni, Setayesh Nematollahi, Kevin Thomas Mathew, Viane Favennec, Lucia Liceran, Cara Aldenhoff-Kelly, Maria Alcocer Valdivieso, Simon Trent, Nasrollah Moradikor · 2026 · International Journal of Biological Macromolecules
94. Pharmacoepigenetics of Memantine in Dementia
    Yıldız Dinçer · 2019 · Elsevier eBooks
95. Effect of Memantine on Expression of NAT-Rad18, Rad18 and Sorl1 Genes in Rat Model of Alzheimer's Disease
    Parisa Azadfar, Zahra Noormohammadi, Maryam Noroozıan, Akram Eidi, Pejman Mortazavi · 2023 · Journal of Advances in Medical and Biomedical Research
96. Calcium handling: a strategy to fight neurodegeneration in Alzheimer’s disease
    Livia La Barbera, Elena Spoleti, Marcello D’Amelio · 2023 · Neural Regeneration Research
97. The Relationship between Alzheimer's Disease and Ferroptosis: A Bibliometric Study Based on Citespace
    Fengwen Lin, Xiaolu Yang, Linqin Li, Jie Chen, Xuxiang Zheng, Lihua Qiu, Shaorui Shi, Bin Nie · 2024 · Current Alzheimer Research
98. Placebo Response in Fragile X‐associated Tremor/Ataxia Syndrome
    Emily J. Hill, Christopher G. Goetz, Glenn T. Stebbins, Randi Jenssen Hagerman, Bichun Ouyang, Deborah A. Hall · 2020 · Movement Disorders Clinical Practice
99. Possibilities of drug therapy for vascular cognitive impairment: a critical view and possible compromises
    А. Yu. Emelin, Vladimir Yu. Lobzin · 2020 · Neurology neuropsychiatry Psychosomatics
100. NMDA receptor antagonists in the treatment of neurological diseases
     Irina Sergeyevna Preobrazhenskaya · 2020 · Neurology neuropsychiatry Psychosomatics